Aptadir Therapeutics: Funding, Investors & Team (Oct 2026)
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.
Aptadir Therapeutics has raised $45.5M across 1 funding round on record, the most recent a Seed of $45.5M announced in Sep 2026.
That round is in line with the $45M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aptadir Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Aptadir Therapeutics Funding Rounds
Aptadir Therapeutics Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Aptadir Therapeutics Founders and Leadership Team
Contact details for the Aptadir Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Aptadir Therapeutics Funding Compared to Other Biotechnology Startups
Aptadir Therapeutics' latest round of $45.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aptadir Therapeutics in Biotechnology and Milan
Companies Similar to Aptadir Therapeutics
Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Senza Research is a healthcare and research company that offers a platform for clinical research to help make…
Delova Biotech specializes in the field of pain treatment.
Billding is a fintech startup that provides a customizable package of home services to its users.
Underdogs Group provides MarTech and AI solutions for marketing and customer engagement.
QSensAto is a quantum sensing company specializing in the development and research of integrated vapor cells…
Tender is an integrated service that allows boutiques and e-commerce to deliver.
Complaion is a compliance technology company that provides software services for regulatory compliance and…
Kubernetes multi-tenancy made easy
Gamindo is a gaming platform where people can convert time spent by playing video games in donations to…
Dialybrid provides research, development concerning, and bio-hybrid materials for novel medical devices.
Aptadir Therapeutics Funding FAQs
What does Aptadir Therapeutics do?
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.
How much funding has Aptadir Therapeutics raised?
Aptadir Therapeutics has raised $45.5M across 1 round on record. The most recent is a Seed of $45.5M announced in Sep 2026.
When did Aptadir Therapeutics last raise funding?
Aptadir Therapeutics' most recent funding round on record is a Seed of $45.5M, announced in Sep 2026.
Who has invested in Aptadir Therapeutics?
Investors on record for Aptadir Therapeutics include CDP Venture Capital, XGEN Venture, 4BIO Capital, Evotec, Indaco Venture Partners. FundedIQ records 11 investors in total.
Who founded Aptadir Therapeutics?
FundedIQ lists Giovanni Amabile (Founder, Executive Chairman and CEO), Marcin Kortylewski (Co-Founder) at Aptadir Therapeutics.
Where is Aptadir Therapeutics headquartered?
Aptadir Therapeutics is based in Milan, Italy.
How many employees does Aptadir Therapeutics have?
Aptadir Therapeutics is in the 1-10 employee band.
When was Aptadir Therapeutics founded?
Aptadir Therapeutics was founded in 2024.
How does Aptadir Therapeutics' funding compare to other Biotechnology startups?
Aptadir Therapeutics' latest round of $45.5M is in line with the $45M median round size for Biotechnology companies on FundedIQ across 7 tracked companies over the last two years.
About FundedIQ's Aptadir Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aptadir Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.